Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tsuruhara Seiyaku is a Japanese pharmaceutical company specializing in the development, manufacture, and distribution of generic ethical drugs. Founded in 1947 and headquartered in Ikeda, Osaka, the company produces a wide range of oral and external medications, including tablets, capsules, and liquid formulations. Tsuruhara Seiyaku is committed to providing high-quality, cost-effective healthcare solutions to the Japanese market. Their portfolio covers numerous therapeutic areas, ranging from cardiovascular and metabolic diseases to central nervous system disorders. The company operates its own manufacturing facilities, ensuring strict adherence to Japanese Good Manufacturing Practice (GMP) standards. As a member of the Japan Generic Medicines Association, they play a vital role in supporting the sustainability of the national healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tsuruhara Seiyaku.